ST.
JOSEPH, Mo., May 3, 2024
/PRNewswire/ -- Boehringer Ingelheim, a global leader in animal
health, celebrated a new and innovative laboratory space at its
St. Joseph, Mo. location by
hosting a ribbon cutting. This state-of-the-art facility is set to
revolutionize the development of future products, including
biotherapeutics.
The new laboratory is a testament to Boehringer's commitment to
innovation and excellence. This unique late-stage R&D
laboratory, the only one of its kind in the US, is designed to
streamline the process of transitioning products from development
to manufacturing, enhancing our ability to serve animals better.
The lab's flexible design and proprietary equipment, which allows
scientists to mimic operations, removes hurdles of transfers and
maximizes efficiency.
"As we venture into exciting new areas of innovation, this
facility will play a pivotal role and will be instrumental in
driving R&D for future products," said Caroline Belmont, Vice President of US Global
Innovation, Boehringer Ingelheim.
Boehringer's St. Joseph
location is a key site within the company's global operations. This
location is primarily dedicated to the product development and
production of animal health products for livestock and horses. The
opening of this new laboratory underscores the company's dedication
to leading the industry in vaccine development and manufacturing –
and to the community in which it operates.
"Boehringer Ingelheim is not just a global leader in animal
health – they are a part of the fabric of our community," said
Kim Young, President KC Animal
Health Corridor. "This facility underscores Boehringer's dedication
to leading the industry in research, development and manufacturing.
The heart of the Corridor are the companies choosing to invest in
the region."
"Boehringer has a strong presence in the Midwest, with key
facilities and operations contributing significantly to its global
operations," said Belmont. "This region is a crucial hub for the
global animal health industry due to its rich agricultural heritage
and extensive livestock farming. Boehringer's strategic positioning
in this community allows it to leverage local resources and
expertise, playing a pivotal role in advancing the global animal
health industry."
For more information and to download the media kit, visit
boehringer-ingelheim.com/us/animal-health.
About Boehringer Ingelheim - Animal Health
business
Boehringer Ingelheim provides innovation for preventing and
treating diseases in animals. The company offers a wide range of
vaccines, parasite-control products, and medicines for pets,
horses, and livestock to veterinarians, animal owners, farmers, and
governments. As a leader in animal health, Boehringer Ingelheim
values that the health of humans and animals is deeply connected
and strives to make a difference for people, animals, and society.
Learn more at www.boehringer-ingelheim.com/animal-health
View original
content:https://www.prnewswire.com/news-releases/boehringer-ingelheim-unveils-new-rd-laboratory-in-st-joseph-mo-pioneering-the-future-of-animal-health-products-302135597.html
SOURCE Boehringer Ingelheim